POSA84 Budget Impact of Larotrectinib for NTRK Fusion Positive Solid Tumors in Greece von Kontoudis, I, Kalogeropoulou, M

Volltext

The Economic Burden of Treating Thalassemia In Greece von Geitona, M, Karagianni, V, Kattamis, A, Voskaridou, E, Drosou, M, Vini, D, Kalogeropoulou, M

Volltext

Impact of Economic Crisis on the Greek Health Care System and on the Population Health von Kaitelidou, D, Kalogeropoulou, M, Galanis, P, Theodorou, M, Charalambous, G, Liaropoulos, L

Volltext

Process Mapping to Capture Breast Cancer Patients' Journey in Greek Public Oncological Hospitals von Kaitelidou, D, Kalogeropoulou, M, Katostaras, T, Minogiannis, P, Skitsou, A, Siskou, O, Liaropoulos, L

Volltext

Socio-Economic Impact of Alzheimer’s Disease in Greece: Pilot Study von Kaitelidou, D, Kalogeropoulou, M, Mougias, A, Galanis, P, Kontodimopoulos, N, Pasaloglou, S, Siskou, O

Volltext

Which Are the Attitudes of Primary Health Services Users Concerning Cost Sharing Measures in a Period of Economic Crisis in Greece? von Siskou, O, Galanis, P, Kouli, E, Tsavalias, K, Kaitelidou, D, Theodorou, M, Prezerakos, P, Spinthouri, M, Vafeiadis, J, Kalogeropoulou, M

Volltext

PBI20 SECUKINUMAB VS. ADALIMUMAB AND INFLIXIMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: A COST PER RESPONDER ANALYSIS AT 52 WEEKS FROM A GREEK PERSPECTIVE von Daoussis, D., Theofanidis, N., Kalogeropoulou, M.

Volltext

Pharmaceutical Expenditure, Clinical Outcomes and Expenditures on Other Health Services von Siskou, O, Galanis, P, Tsavalias, K, Kalogeropoulou, M, Kaitelidou, D, Pasaloglou, S, Schneider, M, Liaropoulos, L

Volltext

Evaluation of Selected Ken-Drgs in Greek Public Hospitals: The Degree to Which they Reflect Actual Expenditure and Average Length of Stay von Siskou, O, Galanis, P, Kaitelidou, D, Kalogeropoulou, M, Kouli, E, Thireos, E, Vafeiadis, J, Theodorou, M, Prezerakos, P, Lemonidou, C, Liaropoulos, L

Volltext

HTA116 Cost-Effectiveness of Nirmatrelvir/Ritonavir for the Treatment of Outpatient Sars-Cov-2 in Adult Patients at Risk for Developing Severe Disease in Greece von Kalogeropoulou, M., Barmpouni, M., Grammelis, V., Rousakis, A., Livieratos, A., Paraskevis, D., Zisimopoulou, O.

Volltext

PND118 - PERCEPTIONS AND NEEDS OF PATIENTS WITH MIGRAINE IN GREECE: A FOCUS GROUP STUDY von Ouzounidou, E, Katsara, M, Kalogeropoulou, M

Volltext

PHS84 Analyzing Pharmaceutical Expenditure in Greece:Unwinding Ariadne's Clue von Siskou, O, Kaitelidou, D, Schneider, M, Kalogeropoulou, M, Tsavalias, K, Passaloglou, S, Kouli, E, Galanis, P, Kontozamanis, V, Liaropoulos, L

Volltext

PHP95 Efficiency of Greek Hospitals: Best Practices of Three Top-Performing Hospitals von Kaitelidou, D, Kalogeropoulou, M, Pasaloglou, S, Letsios, A, Tsiata, K, Kyriazi, M, Galanakis, D, Maltezaki, E, Asithianakis, P, Liaropoulos, L

Volltext

PND55 - A Cost-Effectiveness Analysis of Fingolimod Versus Dimethyl Fumarate As A Second-Line Disease Modifying Treatment In Patients With Highly Active Relapsing-Remitting Multipl... von Raikou, M, Kalogeropoulou, M, Rombopoulos, G

Volltext

A Cost-Effectiveness Analysis of Fingolimod Versus Dimethyl Fumarate As A Second-Line Disease Modifying Treatment In Patients With Highly Active Relapsing-Remitting Multiple Sclero... von Raikou, M, Kalogeropoulou, M, Rombopoulos, G

Volltext

Cost-Effectiveness Analysis of Vildagliptin vs. Glimepiride as Add-On to Metformin in the Management of Type 2 Diabetes Mellitus in Greece von Kousoulakou, H, Kalogeropoulou, M, Panitti, E

Volltext

PDB62 - Cost-Effectiveness Analysis of Vildagliptin vs. Glimepiride as Add-On to Metformin in the Management of Type 2 Diabetes Mellitus in Greece von Kousoulakou, H, Kalogeropoulou, M, Panitti, E

Volltext

PCV74 COST-EFFECTIVENESS OF RIVAROXABAN 2.5MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE von Kalogeropoulou, M., Gkouvitsos, I., Barlogiannis, T., Bowrin, K., Briere, J.B., Millier, A., Karabis, A.

Volltext

PCV67 BUDGET IMPACT OF RIVAROXABAN 2.5MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE von Kalogeropoulou, M., Gkouvitsos, I., Barlogiannis, T., Bowrin, K., Briere, J.B., Millier, A., Karabis, A.

Volltext

PMU28 - A CROSS INDICATION BUDGET IMPACT ANALYSIS OF SECUKINUMAB: A GREEK PERSPECTIVE von Kalogeropoulou, M, Kushwaha, S, Jain, M, Gunta, P, Verroiou, I, Passa, O

Volltext